INNOVIVA, INC. Tax Withholding Paid on Stock Awards
INNOVIVA, INC. (INVA) reported Tax Withholding Paid on Stock Awards of $252.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-05
- INNOVIVA, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $94.00K, a 291.67% increase year-over-year.
- INNOVIVA, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $158.00K, a 135.82% increase year-over-year.
- INNOVIVA, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $27.00K, a 42.11% increase year-over-year.
- INNOVIVA, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $25.00K, a 38.89% increase year-over-year.
- INNOVIVA, INC. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $143.00K, a 0.70% increase from fiscal 2024.
- INNOVIVA, INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $142.00K, a 84.42% increase from fiscal 2023.
- INNOVIVA, INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $77.00K, a 6.10% decline from fiscal 2022.
- INNOVIVA, INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $82.00K, a 36.67% increase from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $252.00K 10-Q · filed 2026-08-05 | $279.00K derived: sum of 3 quarters · filed 2026-08-05 | $304.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $158.00K 10-Q · filed 2026-05-06 | $185.00K derived: sum of 2 quarters · filed 2026-05-06 | $210.00K derived: sum of 3 quarters · filed 2026-05-06 | $234.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $52.00K derived: sum of 2 quarters · filed 2026-02-25 | $76.00K derived: sum of 3 quarters · filed 2026-08-05 | $143.00K 10-K · filed 2026-02-25 |
| 2025-09-30 | $25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $49.00K derived: sum of 2 quarters · filed 2026-08-05 | $116.00K 10-Q · filed 2025-11-05 | $135.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $91.00K 10-Q · filed 2026-08-05 | $110.00K derived: sum of 3 quarters · filed 2026-08-05 | $128.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $67.00K 10-Q · filed 2026-05-06 | $86.00K derived: sum of 2 quarters · filed 2026-05-06 | $104.00K derived: sum of 3 quarters · filed 2026-05-06 | $125.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $37.00K derived: sum of 2 quarters · filed 2026-02-25 | $58.00K derived: sum of 3 quarters · filed 2026-02-25 | $142.00K 10-K · filed 2026-02-25 |
| 2024-09-30 | $18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $39.00K derived: sum of 2 quarters · filed 2025-11-05 | $123.00K 10-Q · filed 2025-11-05 | $135.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $105.00K 10-Q · filed 2025-08-06 | $117.00K derived: sum of 3 quarters · filed 2026-02-25 | $128.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $84.00K 10-Q · filed 2025-05-07 | $96.00K derived: sum of 2 quarters · filed 2026-02-25 | $107.00K derived: sum of 3 quarters · filed 2026-02-25 | $138.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $23.00K derived: sum of 2 quarters · filed 2026-02-25 | $54.00K derived: sum of 3 quarters · filed 2026-02-25 | $77.00K 10-K · filed 2026-02-25 |
| 2023-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $42.00K derived: sum of 2 quarters · filed 2024-11-06 | $65.00K 10-Q · filed 2024-11-06 | $76.00K derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $54.00K 10-Q · filed 2024-07-31 | $65.00K derived: sum of 3 quarters · filed 2025-02-26 | $77.00K derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $23.00K 10-Q · filed 2024-05-08 | $34.00K derived: sum of 2 quarters · filed 2025-02-26 | $46.00K derived: sum of 3 quarters · filed 2025-02-26 | $59.00K derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $23.00K derived: sum of 2 quarters · filed 2025-02-26 | $36.00K derived: sum of 3 quarters · filed 2025-02-26 | $82.00K 10-K · filed 2025-02-26 |
| 2022-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $25.00K derived: sum of 2 quarters · filed 2023-11-01 | $71.00K 10-Q · filed 2023-11-01 | $84.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $59.00K 10-Q · filed 2023-08-02 | $72.00K derived: sum of 3 quarters · filed 2024-03-05 | $84.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | $46.00K 10-Q · filed 2023-05-09 | $59.00K derived: sum of 2 quarters · filed 2024-03-05 | $71.00K derived: sum of 3 quarters · filed 2024-03-05 | $81.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | $13.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-05 | $25.00K derived: sum of 2 quarters · filed 2024-03-05 | $35.00K derived: sum of 3 quarters · filed 2024-03-05 | $60.00K 10-K/A · filed 2024-03-05 |
| 2021-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $22.00K derived: sum of 2 quarters · filed 2022-11-09 | $47.00K 10-Q · filed 2022-11-09 | $56.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $35.00K 10-Q · filed 2022-07-27 | $44.00K derived: sum of 3 quarters · filed 2023-02-28 | $55.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $25.00K 10-Q · filed 2022-05-05 | $34.00K derived: sum of 2 quarters · filed 2023-02-28 | $45.00K derived: sum of 3 quarters · filed 2023-02-28 | $62.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $20.00K derived: sum of 2 quarters · filed 2023-02-28 | $37.00K derived: sum of 3 quarters · filed 2023-02-28 | $92.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | $28.00K derived: sum of 2 quarters · filed 2021-10-27 | $83.00K 10-Q · filed 2021-10-27 | $91.00K derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $72.00K 10-Q · filed 2021-07-29 | $80.00K derived: sum of 3 quarters · filed 2022-03-17 | $87.00K derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-03-31 | $55.00K 10-Q · filed 2021-04-28 | $63.00K derived: sum of 2 quarters · filed 2022-03-17 | $70.00K derived: sum of 3 quarters · filed 2022-03-17 | $79.00K derived: sum of 4 quarters · filed 2022-03-17 |
| 2019-12-31 | $8.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-17 | $15.00K derived: sum of 2 quarters · filed 2022-03-17 | $24.00K derived: sum of 3 quarters · filed 2022-03-17 | $89.00K 10-K/A · filed 2022-03-17 |
| 2019-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $16.00K derived: sum of 2 quarters · filed 2020-10-28 | $81.00K 10-Q · filed 2020-10-28 | $72.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $74.00K 10-Q · filed 2020-07-29 | $65.00K derived: sum of 3 quarters · filed 2021-02-25 | $307.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $65.00K 10-Q · filed 2020-04-29 | $56.00K derived: sum of 2 quarters · filed 2021-02-25 | $298.00K derived: sum of 3 quarters · filed 2021-02-25 | $527.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $233.00K derived: sum of 2 quarters · filed 2021-02-25 | $462.00K derived: sum of 3 quarters · filed 2021-02-25 | $3.07M 10-K · filed 2021-02-25 |
| 2018-09-30 | $242.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $471.00K derived: sum of 2 quarters · filed 2019-10-30 | $3.08M 10-Q · filed 2019-10-30 | $4.03M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | $229.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $2.84M 10-Q · filed 2019-07-24 | $3.79M derived: sum of 3 quarters · filed 2020-02-19 | $4.12M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | $2.61M 10-Q · filed 2019-05-01 | $3.56M derived: sum of 2 quarters · filed 2020-02-19 | $3.89M derived: sum of 3 quarters · filed 2020-02-19 | $4.19M derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | $945.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $1.28M derived: sum of 2 quarters · filed 2020-02-19 | $1.57M derived: sum of 3 quarters · filed 2020-02-19 | $2.13M 10-K · filed 2020-02-19 |
| 2017-09-30 | $336.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $630.00K derived: sum of 2 quarters · filed 2018-10-31 | $1.18M 10-Q · filed 2018-10-31 | $1.38M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-06-30 | $294.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $847.00K 10-Q · filed 2018-07-26 | $1.04M derived: sum of 3 quarters · filed 2019-02-19 | $1.33M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-03-31 | $553.00K 10-Q · filed 2018-05-04 | $748.00K derived: sum of 2 quarters · filed 2019-02-19 | $1.03M derived: sum of 3 quarters · filed 2019-02-19 | $1.19M derived: sum of 4 quarters · filed 2019-02-19 |
| 2016-12-31 | $195.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $482.00K derived: sum of 2 quarters · filed 2019-02-19 | $637.00K derived: sum of 3 quarters · filed 2019-02-19 | $1.08M 10-K · filed 2019-02-19 |
| 2016-09-30 | $287.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $442.00K derived: sum of 2 quarters · filed 2017-11-03 | $884.00K 10-Q · filed 2017-11-03 | $955.00K derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | $155.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $597.00K 10-Q · filed 2017-08-08 | $668.00K derived: sum of 3 quarters · filed 2018-02-23 | $668.00K derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | $442.00K 10-Q · filed 2017-05-05 | $513.00K derived: sum of 2 quarters · filed 2018-02-23 | $513.00K derived: sum of 3 quarters · filed 2018-02-23 | $1.97M derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | $71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $71.00K derived: sum of 2 quarters · filed 2018-02-23 | $1.53M derived: sum of 3 quarters · filed 2018-02-23 | $2.19M 10-K · filed 2018-02-23 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $1.46M derived: sum of 2 quarters · filed 2016-11-03 | $2.12M 10-Q · filed 2016-11-03 | |
| 2015-06-30 | $1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $2.12M 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | $661.00K 10-Q · filed 2016-05-05 | |||
| 2014-12-31 | $5.66M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |